(Q47428951)

16 January 2018

title

Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity (English)

1 reference

16 January 2018

0 references

Dexiang Chen

1

1 reference

16 January 2018

Melissa Burger

2

1 reference

16 January 2018

Qili Chu

3

1 reference

16 January 2018

Ryan Endres

4

1 reference

16 January 2018

Cindy Zuleger

5

1 reference

16 January 2018

Hansi Dean

6

1 reference

16 January 2018

Lendon G Payne

7

1 reference

16 January 2018

publication date

1 July 2004

1 reference

16 January 2018

published in

Virus Research

1 reference

16 January 2018

volume

103

1 reference

16 January 2018

issue

1-2

1 reference

16 January 2018

page(s)

147-153

1 reference

16 January 2018

Anatomical mapping of epidermal Langerhans cell densities in adults

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.027

The skin immune system: progress in cutaneous biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.027

An electron microscopic study of the fibrillar density in the normal human stratum corneum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.027

Epidermal powder immunization using non-toxic bacterial enterotoxin adjuvants with influenza vaccine augments protective immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.027

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.027

Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.027

Epidermal powder immunization with a recombinant HIV gp120 targets Langerhans cells and induces enhanced immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.027

Distribution of ATPase-positive Langerhans cells in normal adult human skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.027

Prevention and early treatment of influenza in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.027

Global Eradication of Smallpox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.027

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.027

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.027

Structure and organization of mammalian stratum corneum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.027

Cytokine networks in the skin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.027

Single-radial-immunodiffusion as an in vitro potency assay for human inactivated viral vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.027

Role of cytokines in epidermal Langerhans cell migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.027

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIRUSRES.2004.02.027

1 reference

16 January 2018

1 reference

16 January 2018